Tumor heterogeneity is a hallmark of neuroblastoma and prognosis can be dismal in the presence of high-risk factors such as N-myc gene amplification, aneuploidy, genetic rearrangement, and age at presentation. The gene discussed is MYCN; the disease is neoplasm.